These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

471 related articles for article (PubMed ID: 25062866)

  • 21. G5-PEG PAMAM dendrimer incorporating nanostructured lipid carriers enhance oral bioavailability and plasma lipid-lowering effect of probucol.
    Qi R; Li YZ; Chen C; Cao YN; Yu MM; Xu L; He B; Jie X; Shen WW; Wang YN; van Dongen MA; Liu GQ; Banaszak Holl MM; Zhang Q; Ke X
    J Control Release; 2015 Jul; 210():160-8. PubMed ID: 26003044
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intranasal Surface-Modified Mosapride Citrate-Loaded Nanostructured Lipid Carriers (MOS-SMNLCs) for Treatment of Reflux Diseases: In vitro Optimization, Pharmacodynamics, and Pharmacokinetic Studies.
    Hammad RW; Sanad RAB; Abdelmalk NS; Aziz RL; Torad FA
    AAPS PharmSciTech; 2018 Nov; 19(8):3791-3808. PubMed ID: 30280358
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Formulation of intranasal surface engineered nanostructured lipid carriers of rotigotine: Full factorial design optimization, in vitro characterization, and pharmacokinetic evaluation.
    Zafar A; Awad Alsaidan O; Alruwaili NK; Sarim Imam S; Yasir M; Saad Alharbi K; Singh L; Muqtader Ahmed M
    Int J Pharm; 2022 Nov; 627():122232. PubMed ID: 36155794
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rifampicin loaded mannosylated cationic nanostructured lipid carriers for alveolar macrophage-specific delivery.
    Song X; Lin Q; Guo L; Fu Y; Han J; Ke H; Sun X; Gong T; Zhang Z
    Pharm Res; 2015 May; 32(5):1741-51. PubMed ID: 25407545
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In-vitro and in-vivo evaluation of chitosan-based thermosensitive gel containing lorazepam NLCs for the treatment of status epilepticus.
    Taymouri S; Minaiyan M; Ebrahimi F; Tavakoli N
    IET Nanobiotechnol; 2020 Apr; 14(2):148-154. PubMed ID: 32433032
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cysteine-Functionalized Nanostructured Lipid Carriers for Oral Delivery of Docetaxel: A Permeability and Pharmacokinetic Study.
    Fang G; Tang B; Chao Y; Xu H; Gou J; Zhang Y; Xu H; Tang X
    Mol Pharm; 2015 Jul; 12(7):2384-95. PubMed ID: 25974386
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Formulation of intranasal mucoadhesive temperature-mediated in situ gel containing ropinirole and evaluation of brain targeting efficiency in rats.
    Khan S; Patil K; Bobade N; Yeole P; Gaikwad R
    J Drug Target; 2010 Apr; 18(3):223-34. PubMed ID: 20030503
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preparation and Characterization of Minoxidil Loaded Nanostructured Lipid Carriers.
    Wang W; Chen L; Huang X; Shao A
    AAPS PharmSciTech; 2017 Feb; 18(2):509-516. PubMed ID: 27120090
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel surface modified solid lipid nanoparticles as intranasal carriers for ropinirole hydrochloride: application of factorial design approach.
    Pardeshi CV; Rajput PV; Belgamwar VS; Tekade AR; Surana SJ
    Drug Deliv; 2013; 20(1):47-56. PubMed ID: 23311653
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhanced brain delivery with lower hepatic exposure of lazaroid loaded nanostructured lipid carriers developed using a design of experiment approach.
    Gadgil P; Shah J; Chow DS
    Int J Pharm; 2018 Jun; 544(1):265-277. PubMed ID: 29689367
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intranasal delivery of doxepin: enhancing brain targeting efficiency utilizing nanostructured lipid carriers for a biopharmaceutics drug disposition classification system class-I drug.
    Patel HP; Vasandia AV; Jha R; Desai BV; Desai DT; Dedhiya PP; Vyas BA; Maulvi FA
    Pharm Dev Technol; 2024 Jul; 29(6):639-647. PubMed ID: 38980085
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Implications of formulation design on lipid-based nanostructured carrier system for drug delivery to brain.
    Salunkhe SS; Bhatia NM; Bhatia MS
    Drug Deliv; 2016 May; 23(4):1306-16. PubMed ID: 25080227
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of the in vitro differential protein adsorption patterns of didanosine-loaded nanostructured lipid carriers (NLCs) for potential targeting to the brain.
    Kasongo KW; Jansch M; Müller RH; Walker RB
    J Liposome Res; 2011 Sep; 21(3):245-54. PubMed ID: 21174528
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Formulation and Evaluation of Niosomal in situ Nasal Gel of a Serotonin Receptor Agonist, Buspirone Hydrochloride for the Brain Delivery via Intranasal Route.
    Mathure D; Madan JR; Gujar KN; Tupsamundre A; Ranpise HA; Dua K
    Pharm Nanotechnol; 2018; 6(1):69-78. PubMed ID: 29380709
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Daidzein-loaded nanostructured lipid carriers-PLGA nanofibers for transdermal delivery.
    Song J; Fan X; Shen Q
    Int J Pharm; 2016 Mar; 501(1-2):245-52. PubMed ID: 26851353
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nanostructured Lipid Carriers (NLCs): Nose-to-Brain Delivery and Theranostic Application.
    Ahmad J; Rizwanullah M; Amin S; Warsi MH; Ahmad MZ; Barkat MA
    Curr Drug Metab; 2020; 21(14):1136-1143. PubMed ID: 32682366
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sucrose ester stabilized solid lipid nanoparticles and nanostructured lipid carriers. I. Effect of formulation variables on the physicochemical properties, drug release and stability of clotrimazole-loaded nanoparticles.
    Das S; Ng WK; Tan RB
    Nanotechnology; 2014 Mar; 25(10):105101. PubMed ID: 24531790
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Brain delivery of valproic acid via intranasal administration of nanostructured lipid carriers: in vivo pharmacodynamic studies using rat electroshock model.
    Eskandari S; Varshosaz J; Minaiyan M; Tabbakhian M
    Int J Nanomedicine; 2011; 6():363-71. PubMed ID: 21499426
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Second generation lipid nanoparticles (NLC) as an oral drug carrier for delivery of lercanidipine hydrochloride.
    Ranpise NS; Korabu SS; Ghodake VN
    Colloids Surf B Biointerfaces; 2014 Apr; 116():81-7. PubMed ID: 24445002
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preparation, macrophages targeting delivery and anti-inflammatory study of pentapeptide grafted nanostructured lipid carriers.
    Zhao C; Fan T; Yang Y; Wu M; Li L; Zhou Z; Jian Y; Zhang Q; Huang Y
    Int J Pharm; 2013 Jun; 450(1-2):11-20. PubMed ID: 23612355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.